InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
67%
T+90 mean return
-0.1%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Egros Fabrice, Director. Director active across 2 companies, notably Syndax Pharmaceuticals Inc. In total, 8 filings have been recorded. History available since 18 May 2021. The latest transaction was disclosed on 2 February 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations8 total
16,000 shares0Common StockSEC:0001562180-22-001072:0
16,000 shares0Common StockSEC:0001562180-22-001072
14,000 shares@ US$8.9322.0% of flowCommon StockSEC:0001562180-21-007180
14,000 shares@ US$8.930.0062% mcap22.0% of flowCommon StockSEC:0001562180-21-007180:0
15,635 shares@ US$7.880.0059% mcap21.0% of flowCommon StockSEC:0001562180-21-005491:0
15,635 shares@ US$7.8821.0% of flowCommon StockSEC:0001562180-21-005491
11,926 shares@ US$7.20100.0% of flowCommon StockSEC:0001562180-21-003670
11,926 shares@ US$7.200.0039% mcap14.0% of flowCommon StockSEC:0001562180-21-003670:0
8 of 8 declarations
About Egros Fabrice
Fabrice Egros is a Director at Syndax Pharmaceuticals Inc. In this role, he participates in the governance of the company, which focuses on developing innovative oncology treatments. Egros contributes to strategy development and operational oversight to ensure the company's success.
